A Case of <sup>123</sup>I-Metaiodobenzylguanidine Scintigraphy-Negative Pheochromocytoma with a Tumor-Developing Mutation in the <i>RET</i> Gene
Pheochromocytoma (PCC) is rare catecholamine-producing endocrine tumor that metastasizes in approximately 10% of cases. As a functional imaging of PCC, <sup>123</sup>I-metaiodobenzylguanidine (MIBG) scintigraphy was established, and some cases of PCC exhibit negative accumulation on MIBG...
Main Authors: | Haremaru Kubo, Yuya Tsurutani, Takashi Sunouchi, Yoshitomo Hoshino, Rei Hirose, Sho Katsuragawa, Noriko Kimura, Jun Saito, Tetsuo Nishikawa |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/15/4624 |
Similar Items
-
High clinical diagnostic accuracy of combined salivary gland and myocardial metaiodobenzylguanidine scintigraphy in the diagnosis of Parkinson’s disease
by: Shuangfang Li, et al.
Published: (2023-01-01) -
Diagnostic Use of Post-therapy <sup>131</sup>I-Meta-Iodobenzylguanidine Scintigraphy in Consolidation Therapy for Children with High-Risk Neuroblastoma
by: Hiroshi Wakabayashi, et al.
Published: (2020-09-01) -
The Value of Histological Algorithms to Predict the Malignancy Potential of Pheochromocytomas and Abdominal Paragangliomas—A Meta-Analysis and Systematic Review of the Literature
by: Adam Stenman, et al.
Published: (2019-02-01) -
Clinical and genetic manifestation of pheochromocytoma patients with RET mutation
by: MA Xiao-sen, WANG Fen, CUI Yun-ying, ZHOU Ting, CHEN Shi, LU Lin, TONG An-li, LI Yu-xiu
Published: (2020-12-01) -
Targeted Radionuclide Therapy for Patients with Metastatic Pheochromocytoma and Paraganglioma: From Low-Specific-Activity to High-Specific-Activity Iodine-131 Metaiodobenzylguanidine
by: Camilo Jimenez, et al.
Published: (2019-07-01)